3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma SAN

Sanofi

SAN Euronext Paris FR0000120578 Biotech & Pharma

Stock factsheet

TickerSAN
ExchangeEuronext Paris
ISINFR0000120578
WKN
SectorBiotech & Pharma
Size class
Market capitalisation

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. We do not have a verified market capitalisation for this company.

Company profile

Sanofi is a French pharmaceutical giant that develops, manufactures and markets prescription medicines, vaccines and over-the-counter healthcare products worldwide. Its therapeutic focus areas include immunology, rare diseases, oncology and diabetes. The company is one of the largest pharmaceutical companies in the world.

Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
SanofiSAN Euronext Paris
4DMEDICAL LIMITED 4DXASX
Abcam LSE
Accor ACEuronext Paris
Alexion Pharmaceuticals ALXNNASDAQ
Amicus Therapeutics FOLDNASDAQ
Ansell ANNASX

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.